Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Nerve Tissue

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,287 public trials 1,279 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.

NCT00032903

Conditions: Glioma, Malignant Glioma, Neoplasms, +6 more
Locations: Rhode Island Hospital Providence, Rhode Island, United States

View Trial Details

Completed

Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38

NCT00912574

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Therapy for Children With Advanced Stage High Risk Neuroblastoma

NCT00186849

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors

NCT00165230

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconness Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

NCT00080054

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasm, +16 more
Locations: Barrow Neurological Institute Phoenix, Arizona, United States

View Trial Details

Completed

Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

NCT00308607

Conditions: Melanoma, Metastatic Melanoma, Neoplasm Metastasis, +14 more
Locations: Kuopio University Hospital Kuopio, Finland

Oulu University Hospital Oulu, Finland

Tampere University Hospital Tampere, Pirkanmaa, Finland

View Trial Details

Completed

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

NCT00120939

Conditions: Adnexal Diseases, Astrocytoma, Breast Diseases, +69 more
Locations: University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

131-I-TM-601 Study in Adults With Solid Tumors

NCT00379132

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +41 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Northwestern University, The Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States

University of Chicago Chicago, Illinois, United States

Tufts - New England Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.

NCT00040573

Conditions: Brain Diseases, Brain Neoplasm, Brain Neoplasms, +13 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

Saint Louis University St Louis, Missouri, United States

View Trial Details

Completed

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

NCT00043368

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +40 more
Locations: Pfizer Investigational Site Berkely, California, United States

Pfizer Investigational Site Gilroy, California, United States

Pfizer Investigational Site Hollister, California, United States

Pfizer Investigational Site Los Angeles, California, United States

View all 32 locations

View Trial Details